The efficacy and safety of Clomipramine Hydrochloride versus Dapoxetine Hydrochloride in Married Heterosexual Men with Premature Ejaculation: A Pragmatic, Randomized Controlled Trial by Debanjan Mandal,
Abstract 
Title of the abstract: The efficacy and safety of Clomipramine Hydrochloride versus 
Dapoxetine Hydrochloride in Married Heterosexual Men with Premature Ejaculation: 
A Pragmatic, Randomized Controlled Trial  
Department: Psychiatry 
Name of the candidate: Dr. Debanjan Mandal 
Degree and subject: MD, Psychiatry 
Name of the guide: Dr. Saumil Dholakia 
Background:  
Dapoxetine and Clomipramine are used in treatment of premature ejaculation. 
Previous trials have demonstrated advantages for Dapoxetine compared to other 
SSRIs in increasing IELT (intravaginal ejaculatory latency time), and reducing 
distress due to premature ejaculation, but no head to head comparisons have been 
conducted against Clomipramine that has been shown to be effective in treatment of 
premature ejaculation. 
Objective: 
Objective of the study was to evaluate the efficacy and safety of six weeks of daily 
oral Clomipramine (25-50 mg) versus Dapoxetine on demand (30 mg; once a week for 
six weeks or for six doses) in the treatment of Premature Ejaculation in heterosexual, 
married men.  
Methods:  
Design: A pragmatic, randomized, parallel group, allocation-concealed, assessor-
blinded, active-controlled trial. 
Setting: Urology and Psychiatry department outpatient services of a teaching general 
and multi-specialty referral hospital in south India.  
Participants: Eighteen married adults presenting with premature ejaculation as a 
result of a non-organic etiology and fulfilling selection criteria, providing informed 
consent for participation.  The target sample size is 120 and the study is ongoing. 
Interventions: Oral Clomipramine (25 mg daily for 1st week and 25-50 mg for 
subsequent 5 weeks, depending on participants’ preference) or oral Dapoxetine 30 mg 
on demand (taken 1-3 hours before intercourse) for 6 doses (recommended once 
weekly for 6 weeks). Additional non-pharmacological interventions were delivered by 
the means of a structured psycho-education module.  
Main outcome measures: The primary outcome is the improvement of premature 
ejaculation at six weeks (or after the first six sexual encounters) which was measured 
by validated patient-reported measures (1) the Premature Ejaculation Profile (PEP) 
that measures changes in the participants subjective sense of control over ejaculation, 
distress related to PE, interpersonal difficulty and satisfaction with sexual intercourse, 
and (2) Clinical Global Impression of Change (CGI-C). Secondary outcomes were 
adverse effects of the interventions using ASEC side effects rating scale, and drug 
discontinuation. 
Results:  
Eighteen patients have been recruited thus far in this ongoing study. Two of them 
have completed the study, both in Clomipramine arm. One patient in Dapoxetine arm 
has dropped out after third week of study, due to adverse drug reactions of insomnia 
and dry mouth. Analysis was done by intention to treat. All three of the participants 
showed trajectory towards improvement in all four domains of PEP. One patient in 
Clomipramine arm reported CGI score of 2 (“better”) at the end of six weeks. 
However, analytical data of outcome measure done on these three patients was not 
statistically significant. Patients receiving Clomipramine reported adverse reactions of 
constipation and drowsiness. 
Descriptive analysis of the baseline profile of patients recruited till now (N=18)  
showed that most of them were young, less than 10th standard educated, presenting 
mostly alone, with very poor control over their ejaculation, poor satisfaction from 
sexual intercourse, extremely distressed in relation to early ejaculation and 
experiencing moderate difficulty in interpersonal functioning due to premature 
ejaculation and have multiple sexual misconceptions-the most prominent being the 
size of the penis and a significant proportion of them have masturbatory guilt.  
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